# V1 Empirics Check — openai/gpt-5.1-codex-mini (Variant A)

**Model:** openai/gpt-5.1-codex-mini
**Variant:** A
**Date:** 2026-03-26T16:40:46.746905

---

**Idea Fidelity**

The paper adheres closely to the manifest’s central research question—whether FATF grey-listing affects remittance costs—by leveraging corridor-level RPW data and a staggered Callaway-Sant’Anna DiD. However, it leaves two key elements of the original idea unaddressed. First, the manifest promised a joint analysis with BIS locational banking statistics to assess financial intermediation, which is entirely absent here. Second, while the manifest emphasised the re-replication-friendly nature of the approach and the use of modern heterogeneity-robust estimation, the paper does not exploit the full scope of staggered cohorts available in the manifest (70+ cohorts are claimed, yet the paper only reports 24). These omissions limit the paper’s ability to speak to the broader “de-risking” story that motivated the idea.

---

**Summary**

The paper presents a null finding that FATF grey-listing does not raise consumer remittance prices. Using corridor-level RPW data for 378 sender-receiver pairs from 2011–2025 and a Callaway-Sant’Anna staggered DiD design, the estimated average treatment effect is 0.16 percentage points (SE = 0.29) and remains null across alternative controls, channel-specific subsamples, provider counts, and exchange rate margins. The author interprets the results as evidence that the retail remittance market, increasingly reliant on MTOs and mobile money rather than correspondent banking, has been insulated from grey-list-induced de-risking.

---

**Essential Points**

1. **Addressing the Missing BIS/Intermediation Evidence.** The manifest promised a joint look at remittance prices and BIS locational banking claims to speak directly to financial intermediation (the purported transmission mechanism). The paper presents only the remittance-price side. Without any evidence on correspondent banking relationships, it is difficult to evaluate the “de-risking” channel—the mechanism the null is supposed to rebut. Even if data limitations precluded the BIS exercise, the paper should explicitly state this or else deliver the promised analysis (e.g., documenting no change in BIS claims around grey-listing). Otherwise the paper only speaks to pricing, not the broader reputational-stigma hypothesis.

2. **Cohort Construction and Treatment Heterogeneity.** The manifest indicated 70+ unique entry cohorts, but the main analysis is limited to 24 cohorts (and 152 treated corridors). It is not clear why the remaining episodes were excluded. If the analysis excludes countries that were grey-listed throughout the sample, this should be discussed explicitly because such countries may systematically differ (e.g., longer spells or more severe AML problems). The paper should clarify the cohort construction, demonstrate robustness to including additional episodes (perhaps via stacking event studies or synthetic controls), and explain whether treatment heterogeneity (e.g., by duration/spell) affects the null.

3. **Exogeneity of Grey-Listing Timing.** The identification argument rests on the mutual evaluation cycle being orthogonal to economic shocks. But grey-listing is plausibly correlated with contemporaneous financial distress (e.g., banking crises, FX shortages) that could influence remittance costs through non-AML channels. The current specification includes only corridor and calendar fixed effects. To bolster credibility, the author should control for receiving-country macroeconomic conditions (GDP growth/fiscal stress, FX regime changes), or at least show that grey-listing is not preceded by systematic deviations in these observables. Absent such controls, the null could still reflect offsetting effects rather than the absence of a treatment effect.

---

**Suggestions**

- **Reintroduce the BIS Intermediation Evidence (or justify its absence).** Given the manifest’s emphasis on BIS claims and the policy narrative about correspondent banking, the paper should either perform the promised BIS analysis or argue convincingly why it could not be done (e.g., data access issues). If feasible, estimate the effect of grey-listing on BIS claims to grey-listed countries, using the same CS-DiD framework, and correlate any changes with remittance price changes. Even if the effect on prices is null, showing losses in line with previous de-risking studies would strengthen the contribution by framing the null as limited pass-through rather than a lack of financial disruption.

- **Expand Treatment Definition and Sample.** Provide a transparent description of the 74 grey-list episodes versus the 24 cohorts actually analyzed. If the exclusion is due to countries already listed at sample start, consider extending the panel earlier (if data allow) or using alternative identification (e.g., focusing on removal events). Including longer-duration spells or delisting episodes could shed light on persistence and ensure the results are not driven by a small subset of milder cases.

- **Heterogeneity and Mechanisms.** The discussion hypothesises that MTOs, mobile money, and price transparency buffer consumers. These can be tested more systematically. For example:
  - Use provider-level shares by channel (banks vs. MTOs vs. mobile money) to show whether corridor exposure to correspondent-banking-intensive providers predicts treatment effects.
  - Interact treatment with receiving-country mobile money penetration or market concentration to test the buffer hypothesis.
  - Re-estimate the main effects separately for corridors with high versus low provider transparency (measured by price dispersion or number of providers) to test the yardstick-competition mechanism.

- **Power and Economic Significance.** While the confidence interval rules out large effects, the paper should report a formal minimum detectable effect (MDE) or power calculation to reassure readers that the null is not simply due to imprecision. This is especially important because the standard errors in the dynamic event study widen quickly. Provide bootstrapped confidence bands or simulated power curves for the pooled and event-study estimates.

- **Parallel Trends Diagnostics.** The event study shows one statistically significant pre-treatment coefficient at $-5$ (though the coefficient is small). Plot the pre-period coefficients with confidence bands or conduct placebo leads (e.g., falsification using future grey-listing) to more transparently demonstrate the credibility of the identifying assumption. Additionally, report whether results change when imposing stricter pre-trend controls (e.g., allowing for country-specific linear trends).

- **Robustness to Alternative Outcome Aggregations.** The main outcome averages provider costs over the corridor. Given that treatment may affect the distribution of provider types within a corridor, consider weighting by provider market share (if available) or estimating the effect on median cost to reduce the influence of outliers. You could also rework the outcome as the cost for the cheapest provider, which may better capture the competitive price that migrants actually face.

- **Clarify Standard Error Choices.** The table notes different clustering levels for CS-DiD and TWFE, but the main specification relies on corridor-level clustering. Given potential spatial correlation across corridors sharing the same receiving country, consider clustering at the receiving-country level (as in the TWFE columns) or using multi-way clustering as a robustness check. Justify why corridor-level clustering is sufficient for the preferred estimator.

- **Discuss Policy Implications with Nuance.** The conclusion draws a relatively strong policy inference (“policy goal is less urgent”). It would improve the paper to nuance this by distinguishing between the welfare of migrants (where costs are unaffected) versus broader financial stability concerns. A short discussion reconciling the null with documented costs on banks (as the paper already notes) would help policymakers.

By addressing the missing BIS component, clarifying the cohort construction, strengthening the exogeneity argument, and expanding the mechanism tests, the paper will better fulfill its promise of providing a rigorous, replication-friendly assessment of sovereign stigma and remittance pricing.
